PGT-A testing typically costs between $3,000 and $6,000 on top of your IVF cycle fees, though the total can range from roughly $3,155 to over $12,600 depending on the clinic, the genetic lab used, and the number of embryos tested. This is one of the most common add-on costs in IVF, and it’s rarely covered by insurance.
What the Base Cost Includes
The price you’re quoted for PGT-A generally covers two things: the embryo biopsy (performed at your fertility clinic on day 5 or 6 of embryo development) and the genetic analysis itself (performed at a separate genetics laboratory). Most clinics charge a flat fee that includes testing for a set number of embryos, often somewhere between four and eight. If you produce more embryos than that baseline number, you’ll pay an additional per-embryo fee, which typically runs $150 to $350 per extra embryo.
The cost varies significantly by genetics lab. Some of the major labs that clinics partner with have different pricing tiers, and your clinic may or may not mark up the lab’s fees. It’s worth asking your clinic for a detailed breakdown of biopsy costs versus lab analysis costs, since these are sometimes billed separately and can arrive as two different charges.
Costs Beyond the Sticker Price
Several expenses tend to catch people off guard. If your fertility clinic doesn’t have an in-house genetics lab (most don’t), your biopsied samples need to be shipped to an external facility. Shipping and courier fees are an additional line item that clinics don’t always mention upfront.
There’s also the question of inconclusive results. Somewhere between 1% and 4% of biopsied embryos come back with no usable result. If you want those embryos re-tested, the embryo has to be thawed, biopsied again, and refrozen, which means paying for another biopsy and another round of testing. This isn’t common, but it’s not rare either, and the cost can add several hundred dollars per embryo.
Mosaic embryos present a different kind of cost consideration. These are embryos with a mix of normal and abnormal cells. They aren’t classified as clearly normal or clearly abnormal, which can leave you paying for long-term cryopreservation storage (typically $500 to $1,000 per year) while you decide what to do with them. Storage fees accumulate quietly over years and are easy to overlook during initial cost planning.
Finally, PGT-A requires that all embryos be frozen after biopsy while you wait for results. That means every PGT-A cycle includes a frozen embryo transfer rather than a fresh one, adding a separate transfer cycle fee if your clinic charges for fresh and frozen transfers differently.
How Long Results Take
Once the genetics lab receives your biopsy samples and payment, results typically come back within about two weeks. Some labs offer expedited turnaround for an additional fee. During this waiting period, your embryos remain frozen, so there’s no time pressure on the embryos themselves. The wait simply means your embryo transfer will happen in a later cycle rather than the same one as your egg retrieval.
Does the Cost Translate to Better Outcomes?
The financial question most people are really asking is whether spending thousands more on PGT-A actually improves their chances of having a baby. The data suggests it does improve outcomes per transfer. In a retrospective study comparing PGT-A cycles to standard IVF, the live birth rate per transfer was 48.3% with PGT-A compared to 34.7% without it. Miscarriage rates were also lower: 25% in the PGT-A group versus 42.6% in the untested group.
Those numbers look compelling, but context matters. PGT-A improves your odds on each individual transfer by screening out embryos that wouldn’t have implanted or would have miscarried. It doesn’t create more viable embryos. If you only produce a small number of embryos and most come back abnormal, PGT-A has saved you the cost and physical toll of failed transfers, but it hasn’t changed your overall probability of success from that cycle. For people who produce many embryos, the value is clearest: you avoid transferring embryos destined to fail and get to a successful pregnancy faster.
The cost-effectiveness also depends heavily on age. Aneuploidy rates rise sharply after 35, meaning older patients are more likely to benefit from screening. For someone under 35 with a good embryo count, the proportion of normal embryos is already high, and testing every embryo may add cost without dramatically changing the outcome.
Insurance and Financial Help
Most insurance plans that cover IVF do not cover PGT-A. It’s almost always an out-of-pocket expense. Some clinics offer payment plans or partner with fertility financing companies that let you spread the cost over months.
Disease-specific grants exist for people using PGT to avoid passing on inherited conditions. For example, the nonprofit HelpCureHD has awarded over 170 IVF grants to families at risk for Huntington’s disease. Similar organizations exist for other genetic conditions like cystic fibrosis and sickle cell disease. These grants typically cover broader IVF costs rather than PGT-A alone, but they can significantly reduce the overall financial burden.
For PGT-A done purely for aneuploidy screening (not a specific genetic disease), grant options are more limited. Your best leverage points are negotiating with your clinic on the per-embryo rate if you have a large batch and asking whether the genetics lab offers any multi-cycle discounts.
A Realistic Cost Estimate
For a single IVF cycle with PGT-A, here’s what the total genetic testing portion realistically looks like:
- Embryo biopsy fee: $1,500 to $3,000
- Genetic lab analysis: $1,500 to $4,000 (varies by number of embryos)
- Additional embryos beyond the base package: $150 to $350 each
- Shipping to external lab: $100 to $400
- Annual embryo storage: $500 to $1,000 per year
All in, most patients spend $3,000 to $6,000 on PGT-A for a single cycle with a moderate number of embryos. Patients with 10 or more embryos, or those using premium labs, can see totals closer to $8,000 or above. These costs sit on top of the $15,000 to $25,000 you’re already paying for the IVF cycle itself, plus medications.